Antisense phosphorothioate oligonucleotides specifically down-regulate cdc25B causing S-phase delay and persistent antiproliferative effects

International Journal of Cancer

Volumn 76, Issue 5, 1998, Pages 720-728

  Garner Hamrick, Peggy A ^a   Fisher, Chris ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGODEOXYNUCLEOTIDE; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE PHOSPHOROTHIOATE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CELL CYCLE S PHASE; CELL SYNCHRONIZATION; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; HELA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ALTERNATIVE SPLICING; CDC25 PHOSPHATASE; CELL CYCLE; CELL CYCLE PROTEINS; CELL DIVISION; DOWN-REGULATION; HELA CELLS; HUMANS; ISOMERISM; OLIGONUCLEOTIDES, ANTISENSE; PHOSPHOPROTEIN PHOSPHATASE; RNA, MESSENGER; S PHASE; SENSITIVITY AND SPECIFICITY; THIONUCLEOTIDES;

EID: 0031799548     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19980529)76:5<720::AID-IJC18>3.0.CO;2-7     Document Type: Article

References (42)

1. BALDIN, V., CANS, C., SUPERTI-FURGA, G. and DUCOMMUN, B., Alternative splicing of the human CDC25B tyrosine phosphatase. Possible implications for growth control? Oncogene, 14, 2485-2495 (1997).
2. BURGESS, T.L. and 14 OTHERS, The antiproliferative activity of c-myb and c-myc antisense oligonucleotides in smooth muscle cells is caused by a nonantisense mechanism. Proc. natl. Acad. Sci. (Wash.), 92, 4051-4055 (1995).
3. DAVIS, F.M., TSAO, T.Y., FOWLER, S.K. and RAO, P.N., Monoclonal antibodies to mitotic cells. Proc. natl. Acad. Sci. (Wash.), 80, 2926-2930 (1983).
4. D'URSO, G., MARRACCINO, R.L., MARSHAK, D.R. and ROBERTS, J.M., Cell cycle control of DNA replication by a homologue from human cells of the p34cdc2 protein kinase. Science, 250, 786-791 (1990).
5. FURNARI, B., RHIND, N. and RUSSELL, P., cdc25 mitotic inducer targeted by chk1 DNA damage checkpoint kinase. Science, 277, 1495-1497 (1997).
6. GABRIELLI, B.G., DE SOUZA, C.P.C., TONKS, I.D., CLARK, J.M., HAYWARD, N.K. and ELLEM, K.A.O., Cytoplasmic accumulation of cdc25B1 phosphatase in mitosis triggers centrosomal microtubule nucleation in HeLa cells. J. Cell Sci., 109, 1081-1093 (1996).
7. GALAKTIONOV, K. and BEACH, D., Specific activation of cdc25 tyrosine phosphatases by B-type cyclins: evidence for multiple roles of mitotic cyclins. Cell, 67, 1181-1194 (1991).
8. GALAKTIONOV, K., CHEN, X. and BEACH, D., cdc25 cell-cycle phosphatase as a target of c-myc. Nature (Lond.), 382, 511-517 (1996).
9. GALAKTIONOV, K., JESSUS, C. and BEACH, D., Raf1 interaction with Cdc25 phosphatase ties mitogenic signal transduction to cell cycle activation. Genes Develop., 9, 1046-1058 (1995a).
10. GALAKTlONOV, K., LEE, A.K., ECKSTEIN, J., DRAETTA, G., MECKLER, J., LODA, M. and BEACH, D., cdc25 phosphatases as potential human oncogenes. Science, 269, 1575-1577 (1995b).
11. GAO, W.-Y., HAN, F.-S., STORM, C., EGAN, W. and CHENG, Y.-C., Phosphorothioate oligonucleotides are inhibitors of human DNA polymerases and RNase H: implications for antisense technology. Mol. Pharmacol., 41, 223-229 (1992).
12. GAUTIER, J., SOLOMON, M.J., BOOHER, R.N., BAZAN, J.F. and KIRSCHNER, M.W., cdc25 is a specific tyrosine phosphatase that directly activates p34cdc2. Cell, 67, 197-211 (1991).
13. GHOSH, M.K., GHOSH, K., DAHL, O. and COHEN, J.S., Evaluation of some properties of a phosphorodithioate oligodeoxyribonucleotide for antisense application. Nucl. Acids Res., 21, 5761-5766 (1993).
14. GIRARD, F., STRAUSFELD, U., CAVADORE, J.C., RUSSELL, P., FERNANDEZ, A. and LAMB, N.J., cdc25 is a nuclear protein expressed constitutively throughout the cell cycle in nontransformed mammalian cells. J. Cell Biol., 118, 785-794 (1992).
15. HOFFMAN, I., CLARKE, P.R., MARCOTE, M.J., KARSENTI, E. and DRAETTA, G., Phosphorylation and activation of human cdc25C by cdc2-cyclin B and its involvement in the self amplification of MPF at mitosis. EMBO J., 12, 53-63 (1993).
16. 1/S transition. EMBO J., 13, 4302-4310 (1994).
17. JINNO, S., SUTO, K., NAGATA, A., IGARASHI, M., KANAOKA, Y., NOJIMA, H. and OKAYAMA, H., cdc25A is a novel phosphatase functioning early in the cell cycle. EMBO J., 13, 1549-1556 (1994).
18. KAKIZUKA, A., SEBASTIAN, B., BORGMEYER, U., HERMANS-BORGMEYER, I., BOLADO, J., HUNTER, T., HOEKSTRA, M.F. and EVANS, R.M., A mouse cdc25 homolog is differentially and developmentally expressed. Genes Develop., 6, 578-590 (1992).
19. KREK, W. and NIGG, E., Mutation of p34cdc2 phosphorylation sites induce premature mitotic events in HeLa cells: evidence for a double block to p34cdc2 kinase activation in vertebrates. EMBO J., 10, 3331-3341 (1991).
20. KUMAGAI, A. and DUNPHY, W.G., The cdc25 protein controls tyrosine dephosphorylation of the cdc2 protein in a cell-free system. Cell, 64, 903-914 (1991).
21. KUMAGAI, A. and DUNPHY, W.G., Purification and molecular cloning of Plx1, a CdC25-regulatory kinase from Xenopus egg extracts. Science, 273, 1377-1380 (1996).
22. LAEMMLI, U.K., Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227, 680-685 (1970).
23. LUNDGREN, K., WALWORTH, N., BOOHER, R., DEMBSKI, M., KIRSCHNER, M. and BEACH, D., mik1 and wee1 cooperate in the inhibitory tyrosine phosphorylation of cdc2. Cell, 64, 1111-1122 (1991).
24. MILLAR, J., MCGOWAN, C.H., LENAERS, G., JONES, R. and RUSSELL, P., p80cdc25 mitotic inducer is the tyrosine phosphatase that activates p34cdc2 kinase in fission yeast. EMBO J., 10, 4301-4309 (1991).
25. MORGAN DA., Principles of CDK regulation. Nature (Lond.), 374, 131-133 (1995).
26. MUELLER, P.R., COLEMAN, T.R., KUMAGAI, A. and DUNPHY, W.G., Myt1: a membrane-associated inhibitory kinase that phosphorylates cdc2 on both threonine-14 and tyrosine-15. Science, 270, 86-90 (1995).
27. NAGATA, A., IGARASHI, M., JINNO, S., SUTO, K. and OKAYAMA, H., An additional homolog of the fission yeast cdc25+ gene occurs in humans and is highly expressed in some cancer cells. New Biol., 3, 959-968 (1991).
28. NEFSKY, B. and BEACH, D., Pub1 acts as an E6-AP-like protein ubiquitin ligase in the degradation of cdc25. EMBO J., 15, 1301-1312 (1996).
29. cdc2/cyclinB activation in hamster BHK21 cells arrested with hydroxyurea. J. Cell Biol., 138, 1105-1116 (1997).
30. NORBURY, C., BLOW, J. and NURSE, P., Regulatory phosphorylation of the p34cdc2 protein kinase in vertebrates. EMBO J., 10, 3321-3329 (1991).
31. PARKER, L. and PIWNICA-WORMS, H., Inactivation of the p34cdc2-cyclin B complex by the human wee1 tyrosine kinase. Science, 257, 1955-1957 (1992).
32. 2 checkpoint control: regulation of 14-3-3 protein binding by phosphorylation of cdc25C on serine-216. Science, 277, 1501-1505 (1997).
33. RUSSELL, P. and NURSE, P., Negative regulation of mitosis by wee1+, a gene encoding a protein kinase homolog. Cell, 49, 559-567 (1987).
34. 2. Proc. natl. Acad. Sci. (Wash.), 87, 5139-5143 (1990).
35. SANCHEZ, Y., WONG, C., THOMA, R.S., RICHMAN, R., WU, Z., PIWNICA-WORMS, H. and ELLEDGE, S.J., Conservation of the chk1 DNA damage checkpoint pathway in mammals: lineage of DNA damage to cdk regulation through cdc25. Science, 277, 1497-1501 (1997).
36. SEBASTIAN, B., KAKIZUKA, A. and HUNTER, T., cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15. Proc. natl. Acad. Sci. (Wash.), 90, 3521-3524 (1993).
37. SHERR, C.J., Mammalian G1 cyclins. Cell, 73, 1059-1065 (1993).
38. cdc2. Cell, 63, 1013-1024 (1990).
39. STEIN, C.A., SUBASINGHE, C., SHINOZUKA, K. and COHEN, J.S., Physiochemical properties of phosphorothiate oligodeoxynucleotides. Nucl. Acids Res., 16, 3209-3221 (1988).
40. STEIN, G.S., STEIN, J.L., LIAN, J.B., LAST, T.J., OWEN, T. and MCCABE, L., Synchronization of normal diploid and transformed mammalian cells. In: J. Cells (ed.), Cell biology: a laboratory handbook. pp. 282-287. Academic Press, San Diego (1994).
41. WAGNER, R.W., MATTEUCCI, M.D., LEWIS, J.G., GUTIERREZ., A.J., MOULDS, C. and FROEHLER, B.C., Antisense gene inhibition by oligonucleotides containing C-5 propyne pyrimidines. Science, 260, 1510-1513 (1993).
42. 2-terminal domain in the catalysis and substrate binding of human Cdc25. J. biol. Chem., 271, 5118-5124 (1996).